Pages
Tissue Viability Update
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/tissue-viability-update
The start of ‘Community First’
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/start-community-first
How does diversity affect the way our colleagues and patients experience health and health services?
Files
Audit Tool (P6).docx
Audit Tool (P6)
2-Musculoskeletal Decision Making Tool Thinking about a Referral - KNEE.pdf
MSK Decision Making Tool - Knee
Appendix 11 - Adult Safeguarding Supervision Non-Case Discussion One to One - Group (P15)
Appendix 11 - Adult Safeguarding Supervision Non-Case Discussion One to One - Group (P15)
Tissue Viability Caseload Management Tool Kit Guidance (G213)
The overall aim of the Guidelines for the Tissue Viability Caseload Management Toolkit is to ensure that Tissue Viability Specialists manage their visits and patient caseloads in a standardised and auditable way across the whole of Tissue Viability Service. The covid19 pandemic has had a profound effect on how care and support for people is provided across all health and care settings thus this guidance has applied the learning from Covid19 to the review and development of the document
L75 - Deviated Toes Closing Wedge Osteotomy
L75 - Deviated Toes Closing Wedge Osteotomy. Podiatric Surgery patient information leaflet.
Dementia Virtual Tour Nov 2022.pdf
Dementia virtual tour training
A9 Irregular Pulse Protocol (S109)
Irregular Pulse Protocol
L309 - Antibiotic Elastomeric Infusor Leaflet for OPAT patients and carers
L309 - Antibiotic Elastomeric Infusor Leaflet for OPAT patients and carers
Guidance for E-referrals via S1 to the Tissue Viability Service (G327)
Guidance for E-referrals via S1 to the Tissue Viability Service
Disclosure Ref 2024111 - Framework Agency Spend Jun 2023 to Mar 24 1 of 2.pdf
Disclosure Ref 2024111 - Framework Agency Spend Jun 2023 to Mar 24 1 of 2